Posts Categorized: Growth & Valuation

Lucky number 7! Apple’s stock is soaring

Posted by & filed under Company Analysis, Growth & Valuation, Industry Analysis.

Description: Apple (AAPL, Tech30) stock surged more than 4% Wednesday afternoon while the broader market was mostly flat. Source: CNNMoney.com – video report Date: Sep 14, 2016 Link: http://money.cnn.com/2016/09/14/investing/apple-stock-iphone-7-samsung/index.html?iid=hp-stack-dom Questions for Discussions: Why has Apple stock soared recently, according to the report? Would you be a buyer now?

Johnson Controls’ CEO Thinks the Corporate Tax System Needs an Overhaul

Posted by & filed under Governments & Regulators, Growth & Valuation, Management Issues.

Description: Alex Molinaroli explains why his company moved to Ireland. Source: Fortune.com – video report Date: Sep 09, 2016 Link: http://for.tn/2cgLsGW Questions for Discussions: Do you believe tax rates in different countries plays an important role in decisions related to mergers and acquisitions? How should governments deal with this issue?

The Bull Is Still Running. So Why Are Investors Tiptoeing?

Posted by & filed under Economic Analysis, Growth & Valuation, Market Analysis.

Description: Wall Street seems unable to make up its mind about risk-taking. Source: NYTimes.com Date: Sep 11, 2016 Link: http://www.nytimes.com/2016/09/11/your-money/the-bull-is-still-running-so-why-are-investors-tiptoeing.html?ref=dealbook&_r=0 Questions for discussion: Summarize the commentary in this report. Do you agree with the analysis and advice to investors?

Mylan’s EpiPen caught the full force of drug price outrage because it was the perfect target, not because it was the only one

Posted by & filed under Governments & Regulators, Growth & Valuation, Industry Analysis, Management Issues.

Description: After the hit taken by Mylan Inc. last week for its sixfold increase in the price of the lifesaving EpiPen, Umer Raffat, an analyst at Evercore ISI, has been receiving a certain request: Investors want to know which companies are making similar moves. Source: MarketWatch.com Date: Sep 02, 2016 Link: http://www.marketwatch.com/story/mylans-epipen-caught-the-full-force-of-drug-price-outrage-because-it-was-the-perfect-target-not-because-it-was-the-only-one-2016-08-31?siteid=nwtwk Questions for Discussions: What… Read more »

This Is the Easiest Way to Invest in Change the World Companies

Posted by & filed under Growth & Valuation, Management Issues.

Description: New funds and ETFs are doing the work for you. Source:  Fortune.com – video report Date:  Aug 19, 2016 Link: http://fortune.com/2016/08/19/social-impact-investment-funds/?iid=leftrail Questions for discussion: Summarize the qualities considered worthy of recognition? Why are investors being directed to ETFs and other instruments focusing on ethical firms?

Tim Cook’s TV Appearances Don’t Bode Well for Apple Stock

Posted by & filed under Company Analysis, Growth & Valuation, Management Issues.

Description: Causing investors to question his credibility Source: Fortune.com – video report Date: May 09, 2016 Link: http://for.tn/1rLV2sy Questions for discussion: What does the report say about the relationship between Tim Cook’s public appearances and Apple’s stock valuation? What are the managerial issues related to his public appearances?